Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer
Condition: Uterine Cervical Cancer Intervention: Drug: SG001 Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials